TherapeuticsMD (TXMD) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD Announces First Quarter 2019 Financial Results
May 6, 2019 4:05 PM EDTBIJUVA Commercial Launch in April 2019
Completed $300 Million Non-Dilutive Term Loan Financing Facility in April 2019
IMVEXXY® Continues Strong Positive Trends for Prescriptions and Patient Refills
Conference Call Scheduled for 4:30 p.m. ET Today
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading womens healthcare company, today announced its commercial and corporate update for the first quarter ended March 31, 2019.
We are pleased with our recent progress on achieving several business objectives, which include the on-time launch of... More
